Medical Care
Global Newborn Disease Screening Market Research Report 2025
- Mar 13, 25
- ID: 130841
- Pages: 78
- Figures: 75
- Views: 46
The global market for Newborn Disease Screening was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Newborn Disease Screening is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Newborn Disease Screening is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Newborn Disease Screening in General Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Newborn Disease Screening include AB Sciex, Agilent Technologies, Bio-Rad Laboratories, Cytiva, Masimo, Medtronic, Natus Medical, PerkinElmer, Zentech Manufacturing, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Newborn Disease Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newborn Disease Screening.
The Newborn Disease Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Newborn Disease Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Newborn Disease Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AB Sciex
Agilent Technologies
Bio-Rad Laboratories
Cytiva
Masimo
Medtronic
Natus Medical
PerkinElmer
Zentech Manufacturing
Segment by Type
Hypothyroidism
Phenylketonuria
Galactosemia
Sickle Cell Disease
Others
Segment by Application
General Hospitals
Specialty Clinics
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Newborn Disease Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Newborn Disease Screening is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Newborn Disease Screening is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Newborn Disease Screening in General Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Newborn Disease Screening include AB Sciex, Agilent Technologies, Bio-Rad Laboratories, Cytiva, Masimo, Medtronic, Natus Medical, PerkinElmer, Zentech Manufacturing, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Newborn Disease Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newborn Disease Screening.
The Newborn Disease Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Newborn Disease Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Newborn Disease Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AB Sciex
Agilent Technologies
Bio-Rad Laboratories
Cytiva
Masimo
Medtronic
Natus Medical
PerkinElmer
Zentech Manufacturing
Segment by Type
Hypothyroidism
Phenylketonuria
Galactosemia
Sickle Cell Disease
Others
Segment by Application
General Hospitals
Specialty Clinics
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Newborn Disease Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Newborn Disease Screening Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hypothyroidism
1.2.3 Phenylketonuria
1.2.4 Galactosemia
1.2.5 Sickle Cell Disease
1.2.6 Others
1.3 Market by Application
1.3.1 Global Newborn Disease Screening Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 General Hospitals
1.3.3 Specialty Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Newborn Disease Screening Market Perspective (2020-2031)
2.2 Global Newborn Disease Screening Growth Trends by Region
2.2.1 Global Newborn Disease Screening Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Newborn Disease Screening Historic Market Size by Region (2020-2025)
2.2.3 Newborn Disease Screening Forecasted Market Size by Region (2026-2031)
2.3 Newborn Disease Screening Market Dynamics
2.3.1 Newborn Disease Screening Industry Trends
2.3.2 Newborn Disease Screening Market Drivers
2.3.3 Newborn Disease Screening Market Challenges
2.3.4 Newborn Disease Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Newborn Disease Screening Players by Revenue
3.1.1 Global Top Newborn Disease Screening Players by Revenue (2020-2025)
3.1.2 Global Newborn Disease Screening Revenue Market Share by Players (2020-2025)
3.2 Global Newborn Disease Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Newborn Disease Screening Revenue
3.4 Global Newborn Disease Screening Market Concentration Ratio
3.4.1 Global Newborn Disease Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Newborn Disease Screening Revenue in 2024
3.5 Global Key Players of Newborn Disease Screening Head office and Area Served
3.6 Global Key Players of Newborn Disease Screening, Product and Application
3.7 Global Key Players of Newborn Disease Screening, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Newborn Disease Screening Breakdown Data by Type
4.1 Global Newborn Disease Screening Historic Market Size by Type (2020-2025)
4.2 Global Newborn Disease Screening Forecasted Market Size by Type (2026-2031)
5 Newborn Disease Screening Breakdown Data by Application
5.1 Global Newborn Disease Screening Historic Market Size by Application (2020-2025)
5.2 Global Newborn Disease Screening Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Newborn Disease Screening Market Size (2020-2031)
6.2 North America Newborn Disease Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Newborn Disease Screening Market Size by Country (2020-2025)
6.4 North America Newborn Disease Screening Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Newborn Disease Screening Market Size (2020-2031)
7.2 Europe Newborn Disease Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Newborn Disease Screening Market Size by Country (2020-2025)
7.4 Europe Newborn Disease Screening Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Newborn Disease Screening Market Size (2020-2031)
8.2 Asia-Pacific Newborn Disease Screening Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Newborn Disease Screening Market Size by Region (2020-2025)
8.4 Asia-Pacific Newborn Disease Screening Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Newborn Disease Screening Market Size (2020-2031)
9.2 Latin America Newborn Disease Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Newborn Disease Screening Market Size by Country (2020-2025)
9.4 Latin America Newborn Disease Screening Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Newborn Disease Screening Market Size (2020-2031)
10.2 Middle East & Africa Newborn Disease Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Newborn Disease Screening Market Size by Country (2020-2025)
10.4 Middle East & Africa Newborn Disease Screening Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AB Sciex
11.1.1 AB Sciex Company Details
11.1.2 AB Sciex Business Overview
11.1.3 AB Sciex Newborn Disease Screening Introduction
11.1.4 AB Sciex Revenue in Newborn Disease Screening Business (2020-2025)
11.1.5 AB Sciex Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Newborn Disease Screening Introduction
11.2.4 Agilent Technologies Revenue in Newborn Disease Screening Business (2020-2025)
11.2.5 Agilent Technologies Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Newborn Disease Screening Introduction
11.3.4 Bio-Rad Laboratories Revenue in Newborn Disease Screening Business (2020-2025)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Cytiva
11.4.1 Cytiva Company Details
11.4.2 Cytiva Business Overview
11.4.3 Cytiva Newborn Disease Screening Introduction
11.4.4 Cytiva Revenue in Newborn Disease Screening Business (2020-2025)
11.4.5 Cytiva Recent Development
11.5 Masimo
11.5.1 Masimo Company Details
11.5.2 Masimo Business Overview
11.5.3 Masimo Newborn Disease Screening Introduction
11.5.4 Masimo Revenue in Newborn Disease Screening Business (2020-2025)
11.5.5 Masimo Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Details
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Newborn Disease Screening Introduction
11.6.4 Medtronic Revenue in Newborn Disease Screening Business (2020-2025)
11.6.5 Medtronic Recent Development
11.7 Natus Medical
11.7.1 Natus Medical Company Details
11.7.2 Natus Medical Business Overview
11.7.3 Natus Medical Newborn Disease Screening Introduction
11.7.4 Natus Medical Revenue in Newborn Disease Screening Business (2020-2025)
11.7.5 Natus Medical Recent Development
11.8 PerkinElmer
11.8.1 PerkinElmer Company Details
11.8.2 PerkinElmer Business Overview
11.8.3 PerkinElmer Newborn Disease Screening Introduction
11.8.4 PerkinElmer Revenue in Newborn Disease Screening Business (2020-2025)
11.8.5 PerkinElmer Recent Development
11.9 Zentech Manufacturing
11.9.1 Zentech Manufacturing Company Details
11.9.2 Zentech Manufacturing Business Overview
11.9.3 Zentech Manufacturing Newborn Disease Screening Introduction
11.9.4 Zentech Manufacturing Revenue in Newborn Disease Screening Business (2020-2025)
11.9.5 Zentech Manufacturing Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Newborn Disease Screening Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hypothyroidism
1.2.3 Phenylketonuria
1.2.4 Galactosemia
1.2.5 Sickle Cell Disease
1.2.6 Others
1.3 Market by Application
1.3.1 Global Newborn Disease Screening Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 General Hospitals
1.3.3 Specialty Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Newborn Disease Screening Market Perspective (2020-2031)
2.2 Global Newborn Disease Screening Growth Trends by Region
2.2.1 Global Newborn Disease Screening Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Newborn Disease Screening Historic Market Size by Region (2020-2025)
2.2.3 Newborn Disease Screening Forecasted Market Size by Region (2026-2031)
2.3 Newborn Disease Screening Market Dynamics
2.3.1 Newborn Disease Screening Industry Trends
2.3.2 Newborn Disease Screening Market Drivers
2.3.3 Newborn Disease Screening Market Challenges
2.3.4 Newborn Disease Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Newborn Disease Screening Players by Revenue
3.1.1 Global Top Newborn Disease Screening Players by Revenue (2020-2025)
3.1.2 Global Newborn Disease Screening Revenue Market Share by Players (2020-2025)
3.2 Global Newborn Disease Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Newborn Disease Screening Revenue
3.4 Global Newborn Disease Screening Market Concentration Ratio
3.4.1 Global Newborn Disease Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Newborn Disease Screening Revenue in 2024
3.5 Global Key Players of Newborn Disease Screening Head office and Area Served
3.6 Global Key Players of Newborn Disease Screening, Product and Application
3.7 Global Key Players of Newborn Disease Screening, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Newborn Disease Screening Breakdown Data by Type
4.1 Global Newborn Disease Screening Historic Market Size by Type (2020-2025)
4.2 Global Newborn Disease Screening Forecasted Market Size by Type (2026-2031)
5 Newborn Disease Screening Breakdown Data by Application
5.1 Global Newborn Disease Screening Historic Market Size by Application (2020-2025)
5.2 Global Newborn Disease Screening Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Newborn Disease Screening Market Size (2020-2031)
6.2 North America Newborn Disease Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Newborn Disease Screening Market Size by Country (2020-2025)
6.4 North America Newborn Disease Screening Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Newborn Disease Screening Market Size (2020-2031)
7.2 Europe Newborn Disease Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Newborn Disease Screening Market Size by Country (2020-2025)
7.4 Europe Newborn Disease Screening Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Newborn Disease Screening Market Size (2020-2031)
8.2 Asia-Pacific Newborn Disease Screening Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Newborn Disease Screening Market Size by Region (2020-2025)
8.4 Asia-Pacific Newborn Disease Screening Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Newborn Disease Screening Market Size (2020-2031)
9.2 Latin America Newborn Disease Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Newborn Disease Screening Market Size by Country (2020-2025)
9.4 Latin America Newborn Disease Screening Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Newborn Disease Screening Market Size (2020-2031)
10.2 Middle East & Africa Newborn Disease Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Newborn Disease Screening Market Size by Country (2020-2025)
10.4 Middle East & Africa Newborn Disease Screening Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AB Sciex
11.1.1 AB Sciex Company Details
11.1.2 AB Sciex Business Overview
11.1.3 AB Sciex Newborn Disease Screening Introduction
11.1.4 AB Sciex Revenue in Newborn Disease Screening Business (2020-2025)
11.1.5 AB Sciex Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Newborn Disease Screening Introduction
11.2.4 Agilent Technologies Revenue in Newborn Disease Screening Business (2020-2025)
11.2.5 Agilent Technologies Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Newborn Disease Screening Introduction
11.3.4 Bio-Rad Laboratories Revenue in Newborn Disease Screening Business (2020-2025)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Cytiva
11.4.1 Cytiva Company Details
11.4.2 Cytiva Business Overview
11.4.3 Cytiva Newborn Disease Screening Introduction
11.4.4 Cytiva Revenue in Newborn Disease Screening Business (2020-2025)
11.4.5 Cytiva Recent Development
11.5 Masimo
11.5.1 Masimo Company Details
11.5.2 Masimo Business Overview
11.5.3 Masimo Newborn Disease Screening Introduction
11.5.4 Masimo Revenue in Newborn Disease Screening Business (2020-2025)
11.5.5 Masimo Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Details
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Newborn Disease Screening Introduction
11.6.4 Medtronic Revenue in Newborn Disease Screening Business (2020-2025)
11.6.5 Medtronic Recent Development
11.7 Natus Medical
11.7.1 Natus Medical Company Details
11.7.2 Natus Medical Business Overview
11.7.3 Natus Medical Newborn Disease Screening Introduction
11.7.4 Natus Medical Revenue in Newborn Disease Screening Business (2020-2025)
11.7.5 Natus Medical Recent Development
11.8 PerkinElmer
11.8.1 PerkinElmer Company Details
11.8.2 PerkinElmer Business Overview
11.8.3 PerkinElmer Newborn Disease Screening Introduction
11.8.4 PerkinElmer Revenue in Newborn Disease Screening Business (2020-2025)
11.8.5 PerkinElmer Recent Development
11.9 Zentech Manufacturing
11.9.1 Zentech Manufacturing Company Details
11.9.2 Zentech Manufacturing Business Overview
11.9.3 Zentech Manufacturing Newborn Disease Screening Introduction
11.9.4 Zentech Manufacturing Revenue in Newborn Disease Screening Business (2020-2025)
11.9.5 Zentech Manufacturing Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Newborn Disease Screening Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Hypothyroidism
Table 3. Key Players of Phenylketonuria
Table 4. Key Players of Galactosemia
Table 5. Key Players of Sickle Cell Disease
Table 6. Key Players of Others
Table 7. Global Newborn Disease Screening Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Newborn Disease Screening Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Newborn Disease Screening Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Newborn Disease Screening Market Share by Region (2020-2025)
Table 11. Global Newborn Disease Screening Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Newborn Disease Screening Market Share by Region (2026-2031)
Table 13. Newborn Disease Screening Market Trends
Table 14. Newborn Disease Screening Market Drivers
Table 15. Newborn Disease Screening Market Challenges
Table 16. Newborn Disease Screening Market Restraints
Table 17. Global Newborn Disease Screening Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Newborn Disease Screening Market Share by Players (2020-2025)
Table 19. Global Top Newborn Disease Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Disease Screening as of 2024)
Table 20. Ranking of Global Top Newborn Disease Screening Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Newborn Disease Screening Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Newborn Disease Screening, Headquarters and Area Served
Table 23. Global Key Players of Newborn Disease Screening, Product and Application
Table 24. Global Key Players of Newborn Disease Screening, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Newborn Disease Screening Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Newborn Disease Screening Revenue Market Share by Type (2020-2025)
Table 28. Global Newborn Disease Screening Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Newborn Disease Screening Revenue Market Share by Type (2026-2031)
Table 30. Global Newborn Disease Screening Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Newborn Disease Screening Revenue Market Share by Application (2020-2025)
Table 32. Global Newborn Disease Screening Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Newborn Disease Screening Revenue Market Share by Application (2026-2031)
Table 34. North America Newborn Disease Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Newborn Disease Screening Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Newborn Disease Screening Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Newborn Disease Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Newborn Disease Screening Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Newborn Disease Screening Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Newborn Disease Screening Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Newborn Disease Screening Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Newborn Disease Screening Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Newborn Disease Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Newborn Disease Screening Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Newborn Disease Screening Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Newborn Disease Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Newborn Disease Screening Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Newborn Disease Screening Market Size by Country (2026-2031) & (US$ Million)
Table 49. AB Sciex Company Details
Table 50. AB Sciex Business Overview
Table 51. AB Sciex Newborn Disease Screening Product
Table 52. AB Sciex Revenue in Newborn Disease Screening Business (2020-2025) & (US$ Million)
Table 53. AB Sciex Recent Development
Table 54. Agilent Technologies Company Details
Table 55. Agilent Technologies Business Overview
Table 56. Agilent Technologies Newborn Disease Screening Product
Table 57. Agilent Technologies Revenue in Newborn Disease Screening Business (2020-2025) & (US$ Million)
Table 58. Agilent Technologies Recent Development
Table 59. Bio-Rad Laboratories Company Details
Table 60. Bio-Rad Laboratories Business Overview
Table 61. Bio-Rad Laboratories Newborn Disease Screening Product
Table 62. Bio-Rad Laboratories Revenue in Newborn Disease Screening Business (2020-2025) & (US$ Million)
Table 63. Bio-Rad Laboratories Recent Development
Table 64. Cytiva Company Details
Table 65. Cytiva Business Overview
Table 66. Cytiva Newborn Disease Screening Product
Table 67. Cytiva Revenue in Newborn Disease Screening Business (2020-2025) & (US$ Million)
Table 68. Cytiva Recent Development
Table 69. Masimo Company Details
Table 70. Masimo Business Overview
Table 71. Masimo Newborn Disease Screening Product
Table 72. Masimo Revenue in Newborn Disease Screening Business (2020-2025) & (US$ Million)
Table 73. Masimo Recent Development
Table 74. Medtronic Company Details
Table 75. Medtronic Business Overview
Table 76. Medtronic Newborn Disease Screening Product
Table 77. Medtronic Revenue in Newborn Disease Screening Business (2020-2025) & (US$ Million)
Table 78. Medtronic Recent Development
Table 79. Natus Medical Company Details
Table 80. Natus Medical Business Overview
Table 81. Natus Medical Newborn Disease Screening Product
Table 82. Natus Medical Revenue in Newborn Disease Screening Business (2020-2025) & (US$ Million)
Table 83. Natus Medical Recent Development
Table 84. PerkinElmer Company Details
Table 85. PerkinElmer Business Overview
Table 86. PerkinElmer Newborn Disease Screening Product
Table 87. PerkinElmer Revenue in Newborn Disease Screening Business (2020-2025) & (US$ Million)
Table 88. PerkinElmer Recent Development
Table 89. Zentech Manufacturing Company Details
Table 90. Zentech Manufacturing Business Overview
Table 91. Zentech Manufacturing Newborn Disease Screening Product
Table 92. Zentech Manufacturing Revenue in Newborn Disease Screening Business (2020-2025) & (US$ Million)
Table 93. Zentech Manufacturing Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
Table 97. Authors List of This Report
List of Figures
Figure 1. Newborn Disease Screening Picture
Figure 2. Global Newborn Disease Screening Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Newborn Disease Screening Market Share by Type: 2024 VS 2031
Figure 4. Hypothyroidism Features
Figure 5. Phenylketonuria Features
Figure 6. Galactosemia Features
Figure 7. Sickle Cell Disease Features
Figure 8. Others Features
Figure 9. Global Newborn Disease Screening Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Newborn Disease Screening Market Share by Application: 2024 VS 2031
Figure 11. General Hospitals Case Studies
Figure 12. Specialty Clinics Case Studies
Figure 13. Newborn Disease Screening Report Years Considered
Figure 14. Global Newborn Disease Screening Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Newborn Disease Screening Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Newborn Disease Screening Market Share by Region: 2024 VS 2031
Figure 17. Global Newborn Disease Screening Market Share by Players in 2024
Figure 18. Global Top Newborn Disease Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Disease Screening as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Newborn Disease Screening Revenue in 2024
Figure 20. North America Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Newborn Disease Screening Market Share by Country (2020-2031)
Figure 22. United States Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Newborn Disease Screening Market Share by Country (2020-2031)
Figure 26. Germany Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Newborn Disease Screening Market Share by Region (2020-2031)
Figure 34. China Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Newborn Disease Screening Market Share by Country (2020-2031)
Figure 42. Mexico Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Newborn Disease Screening Market Share by Country (2020-2031)
Figure 46. Turkey Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. AB Sciex Revenue Growth Rate in Newborn Disease Screening Business (2020-2025)
Figure 50. Agilent Technologies Revenue Growth Rate in Newborn Disease Screening Business (2020-2025)
Figure 51. Bio-Rad Laboratories Revenue Growth Rate in Newborn Disease Screening Business (2020-2025)
Figure 52. Cytiva Revenue Growth Rate in Newborn Disease Screening Business (2020-2025)
Figure 53. Masimo Revenue Growth Rate in Newborn Disease Screening Business (2020-2025)
Figure 54. Medtronic Revenue Growth Rate in Newborn Disease Screening Business (2020-2025)
Figure 55. Natus Medical Revenue Growth Rate in Newborn Disease Screening Business (2020-2025)
Figure 56. PerkinElmer Revenue Growth Rate in Newborn Disease Screening Business (2020-2025)
Figure 57. Zentech Manufacturing Revenue Growth Rate in Newborn Disease Screening Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Newborn Disease Screening Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Hypothyroidism
Table 3. Key Players of Phenylketonuria
Table 4. Key Players of Galactosemia
Table 5. Key Players of Sickle Cell Disease
Table 6. Key Players of Others
Table 7. Global Newborn Disease Screening Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Newborn Disease Screening Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Newborn Disease Screening Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Newborn Disease Screening Market Share by Region (2020-2025)
Table 11. Global Newborn Disease Screening Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Newborn Disease Screening Market Share by Region (2026-2031)
Table 13. Newborn Disease Screening Market Trends
Table 14. Newborn Disease Screening Market Drivers
Table 15. Newborn Disease Screening Market Challenges
Table 16. Newborn Disease Screening Market Restraints
Table 17. Global Newborn Disease Screening Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Newborn Disease Screening Market Share by Players (2020-2025)
Table 19. Global Top Newborn Disease Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Disease Screening as of 2024)
Table 20. Ranking of Global Top Newborn Disease Screening Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Newborn Disease Screening Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Newborn Disease Screening, Headquarters and Area Served
Table 23. Global Key Players of Newborn Disease Screening, Product and Application
Table 24. Global Key Players of Newborn Disease Screening, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Newborn Disease Screening Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Newborn Disease Screening Revenue Market Share by Type (2020-2025)
Table 28. Global Newborn Disease Screening Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Newborn Disease Screening Revenue Market Share by Type (2026-2031)
Table 30. Global Newborn Disease Screening Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Newborn Disease Screening Revenue Market Share by Application (2020-2025)
Table 32. Global Newborn Disease Screening Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Newborn Disease Screening Revenue Market Share by Application (2026-2031)
Table 34. North America Newborn Disease Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Newborn Disease Screening Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Newborn Disease Screening Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Newborn Disease Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Newborn Disease Screening Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Newborn Disease Screening Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Newborn Disease Screening Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Newborn Disease Screening Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Newborn Disease Screening Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Newborn Disease Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Newborn Disease Screening Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Newborn Disease Screening Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Newborn Disease Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Newborn Disease Screening Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Newborn Disease Screening Market Size by Country (2026-2031) & (US$ Million)
Table 49. AB Sciex Company Details
Table 50. AB Sciex Business Overview
Table 51. AB Sciex Newborn Disease Screening Product
Table 52. AB Sciex Revenue in Newborn Disease Screening Business (2020-2025) & (US$ Million)
Table 53. AB Sciex Recent Development
Table 54. Agilent Technologies Company Details
Table 55. Agilent Technologies Business Overview
Table 56. Agilent Technologies Newborn Disease Screening Product
Table 57. Agilent Technologies Revenue in Newborn Disease Screening Business (2020-2025) & (US$ Million)
Table 58. Agilent Technologies Recent Development
Table 59. Bio-Rad Laboratories Company Details
Table 60. Bio-Rad Laboratories Business Overview
Table 61. Bio-Rad Laboratories Newborn Disease Screening Product
Table 62. Bio-Rad Laboratories Revenue in Newborn Disease Screening Business (2020-2025) & (US$ Million)
Table 63. Bio-Rad Laboratories Recent Development
Table 64. Cytiva Company Details
Table 65. Cytiva Business Overview
Table 66. Cytiva Newborn Disease Screening Product
Table 67. Cytiva Revenue in Newborn Disease Screening Business (2020-2025) & (US$ Million)
Table 68. Cytiva Recent Development
Table 69. Masimo Company Details
Table 70. Masimo Business Overview
Table 71. Masimo Newborn Disease Screening Product
Table 72. Masimo Revenue in Newborn Disease Screening Business (2020-2025) & (US$ Million)
Table 73. Masimo Recent Development
Table 74. Medtronic Company Details
Table 75. Medtronic Business Overview
Table 76. Medtronic Newborn Disease Screening Product
Table 77. Medtronic Revenue in Newborn Disease Screening Business (2020-2025) & (US$ Million)
Table 78. Medtronic Recent Development
Table 79. Natus Medical Company Details
Table 80. Natus Medical Business Overview
Table 81. Natus Medical Newborn Disease Screening Product
Table 82. Natus Medical Revenue in Newborn Disease Screening Business (2020-2025) & (US$ Million)
Table 83. Natus Medical Recent Development
Table 84. PerkinElmer Company Details
Table 85. PerkinElmer Business Overview
Table 86. PerkinElmer Newborn Disease Screening Product
Table 87. PerkinElmer Revenue in Newborn Disease Screening Business (2020-2025) & (US$ Million)
Table 88. PerkinElmer Recent Development
Table 89. Zentech Manufacturing Company Details
Table 90. Zentech Manufacturing Business Overview
Table 91. Zentech Manufacturing Newborn Disease Screening Product
Table 92. Zentech Manufacturing Revenue in Newborn Disease Screening Business (2020-2025) & (US$ Million)
Table 93. Zentech Manufacturing Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
Table 97. Authors List of This Report
List of Figures
Figure 1. Newborn Disease Screening Picture
Figure 2. Global Newborn Disease Screening Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Newborn Disease Screening Market Share by Type: 2024 VS 2031
Figure 4. Hypothyroidism Features
Figure 5. Phenylketonuria Features
Figure 6. Galactosemia Features
Figure 7. Sickle Cell Disease Features
Figure 8. Others Features
Figure 9. Global Newborn Disease Screening Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Newborn Disease Screening Market Share by Application: 2024 VS 2031
Figure 11. General Hospitals Case Studies
Figure 12. Specialty Clinics Case Studies
Figure 13. Newborn Disease Screening Report Years Considered
Figure 14. Global Newborn Disease Screening Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Newborn Disease Screening Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Newborn Disease Screening Market Share by Region: 2024 VS 2031
Figure 17. Global Newborn Disease Screening Market Share by Players in 2024
Figure 18. Global Top Newborn Disease Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Disease Screening as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Newborn Disease Screening Revenue in 2024
Figure 20. North America Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Newborn Disease Screening Market Share by Country (2020-2031)
Figure 22. United States Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Newborn Disease Screening Market Share by Country (2020-2031)
Figure 26. Germany Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Newborn Disease Screening Market Share by Region (2020-2031)
Figure 34. China Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Newborn Disease Screening Market Share by Country (2020-2031)
Figure 42. Mexico Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Newborn Disease Screening Market Share by Country (2020-2031)
Figure 46. Turkey Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Newborn Disease Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. AB Sciex Revenue Growth Rate in Newborn Disease Screening Business (2020-2025)
Figure 50. Agilent Technologies Revenue Growth Rate in Newborn Disease Screening Business (2020-2025)
Figure 51. Bio-Rad Laboratories Revenue Growth Rate in Newborn Disease Screening Business (2020-2025)
Figure 52. Cytiva Revenue Growth Rate in Newborn Disease Screening Business (2020-2025)
Figure 53. Masimo Revenue Growth Rate in Newborn Disease Screening Business (2020-2025)
Figure 54. Medtronic Revenue Growth Rate in Newborn Disease Screening Business (2020-2025)
Figure 55. Natus Medical Revenue Growth Rate in Newborn Disease Screening Business (2020-2025)
Figure 56. PerkinElmer Revenue Growth Rate in Newborn Disease Screening Business (2020-2025)
Figure 57. Zentech Manufacturing Revenue Growth Rate in Newborn Disease Screening Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232